How does trauma insurance work for cancer diagnoses?

Cancer is the largest single claim category in Australian Trauma cover, broadly two-thirds of paid claims. Panel policies pay a full benefit for invasive cancer meeting the PDS severity definition and a partial benefit (commonly 10-25%) for carcinoma in situ or early-stage cancers.

The Life Insurance Code of Practice 2019 standardises core cancer definitions for the first $2 million of cover. Beyond this, definitions and partial-benefit structures vary across the panel.

What cancer claims pay (full benefit)

A full Trauma benefit pays for cancers that meet the PDS severity threshold. Across the panel, this is generally invasive cancer evidenced by histopathology showing malignancy and tissue invasion. Examples that typically pay 100%:

• Stage 2 or higher breast, bowel, lung, or pancreatic cancer
• Stage 2 or higher melanoma (above the Breslow depth threshold and Clark Level)
• Acute leukaemia and aggressive lymphoma
• Brain tumours of specified types (malignant or specified benign)
• Other invasive cancers meeting the histopathology threshold

What cancer claims pay partial benefit

A partial benefit pays for less severe cancers and pre-malignant conditions. Across the panel, partial benefits typically cover:

• Carcinoma in situ (cancer cells confined to original site, no tissue invasion)
• Early-stage skin melanoma below the Breslow / Clark threshold for full benefit
• Early-stage prostate cancer (Gleason score below threshold; T1a TNM staging)
• Some early-stage breast, cervical, or testicular cancers

Partial benefit percentages across the panel

| Insurer | Partial benefit examples | PDS reference | |---------|-------------------------|---------------| | AIA | Carcinoma in situ: greater of $10,000 or 10% of Sum Insured. Skin Cancer (early-stage melanoma): greater of $10,000 or 15%. Full sum insured paid for carcinoma in situ of breast where entire breast removed | AIA Priority Protection PDS (9 November 2025), Section 4 | | TAL | Advancement Benefit pays 25% of Benefit Amount to a maximum of $100,000 per event. Includes Early Stage Skin Melanoma, Carcinoma In Situ, Early Stage Chronic Lymphocytic Leukaemia, Diagnosed Benign Brain or Spinal Cord Tumour | TAL Accelerated Protection PDS (12 December 2024), Section 2.3 | | Zurich | Trauma Plus pays partial benefit at 20% of trauma benefit, capped at $20,000 for angioplasty and $100,000 for other partial-payment conditions; cancer in situ included | Zurich Wealth Protection PDS (1 November 2025) | | OnePath | Trauma Comprehensive pays 10% partial on two specific conditions; Premier Cover adds 17 more partial-payment conditions at 20% | OnePath OneCare PDS (1 October 2025), Glossary of trauma conditions page 96 | | ClearView | Trauma Severe Events tier carries the partial-benefit catalogue including early-stage cancers; Trauma definitions updated 5 June 2025 | ClearView ClearChoice PDS (13 May 2024, Update 5 June 2025) | | NEOS | Partial Critical Illness benefits for early-stage cancers; Reinstatement Benefit restricted for early stage prostate cancer or melanoma in situ | NEOS Protection PDS (6 December 2024) | | Encompass | Partial Critical Illness Event definitions for carcinoma in situ and early-stage cancers | Encompass Protection PDS (26 September 2025), page 84 | | Acenda | Partial Critical Illness Event catalogue under Critical Illness Plus | Acenda Insurance PDS (27 September 2025), pages 22-26 | | Futura | Partial Critical Illness Event definitions for early-stage cancers | Futura Protection PDS (1 October 2025), page 92 |

The percentage varies (AIA 10% for some carcinoma in situ categories, 15% for early-stage skin cancer; TAL 25% across Advancement Benefit Events) and the listed body sites differ. Generalisations like "all panel insurers pay 25% partial for carcinoma in situ" are not accurate.

Cancers typically excluded or treated differently

Three categories of cancer commonly do not pay a full Trauma benefit.

• Non-melanoma skin cancers (basal cell carcinoma, squamous cell carcinoma) are typically excluded entirely or covered only under limited circumstances
• Pre-malignant conditions without invasive cancer cells (some dysplasias, intraepithelial neoplasias below threshold) may be excluded or treated as partial benefits
• Cancers in remission at the start of cover are typically excluded as pre-existing conditions for a defined period (commonly 5-10 years)

The Life Insurance Code of Practice (LICOP) 2019

Under LICOP, panel insurers use standardised core medical definitions for cancer (and for heart attack and stroke) for the first $2 million of cover. This was introduced to reduce inconsistency across the panel and make policies easier to compare.

Cites:

• Zurich Wealth Protection PDS (1 November 2025) (LICOP adoption for first $2M)
• OnePath OneCare PDS (1 October 2025) (code-derived definitions apply to first $2M)

For cover above $2 million, insurers may use their own definitions, which can be tighter than LICOP. Read the relevant PDS where you hold high cover.

Medical evidence for cancer claims

A cancer claim requires:

• Histopathology report confirming malignancy and tissue type
• Cancer staging report showing TNM stage, Gleason score (prostate), Breslow depth (melanoma), or other staging
• Oncology specialist report with diagnosis and treatment plan
• Treating doctor confirmation of date of diagnosis

AIA's PDS requires the diagnosis to be confirmed by a "Medical Practitioner and/or legally qualified pathologist" based on "the relevant and reasonably necessary histological material and clinical presentation" (AIA Priority Protection PDS (9 November 2025), Section 4).

The 90-day qualifying period

Most panel Trauma policies exclude cancer claims in the first 90 days of cover. The qualifying period is intended to prevent applications made after symptoms have begun.

• TAL: 3-month qualifying period for Cancer (TAL Accelerated Protection PDS (12 December 2024), Section 2.3)
• OnePath: 90-day qualifying period for listed Trauma conditions including cancer (OnePath OneCare PDS (1 October 2025))
• Encompass: 90-day exclusion period for listed events (Encompass Protection PDS (26 September 2025))

After a partial cancer claim

After a partial benefit is paid, the remaining Trauma sum insured continues at the reduced amount. A future invasive cancer diagnosis can still claim the full benefit (minus the partial already paid), subject to PDS terms.

Note NEOS's specific Reinstatement Benefit restriction on "early stage prostate cancer or early" stage skin cancer (melanoma in situ) (NEOS Protection PDS (6 December 2024)): these conditions may not benefit from full Reinstatement after a claim.

Cancer incidence statistics

For current Australian cancer incidence figures, refer to the Australian Institute of Health and Welfare (AIHW) at aihw.gov.au, which publishes annual cancer statistics.

This is general information, not personal advice.